Topical calcineurin inhibitors labeling: putting the "box" in perspective

Arch Dermatol. 2006 Sep;142(9):1233-5. doi: 10.1001/archderm.142.9.1233.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Cutaneous
  • Calcineurin Inhibitors*
  • Dermatitis, Atopic / drug therapy*
  • Drug Approval
  • Drug Labeling
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Tacrolimus / analogs & derivatives*
  • United States
  • United States Food and Drug Administration

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • pimecrolimus
  • Tacrolimus